首页 > 最新文献

Journal of Endovascular Therapy最新文献

英文 中文
Renal Revascularization With X-Crossing Technique During Complex Aortic Aneurysm Repair Using Branched Endograft. 应用x线交叉技术修复复杂主动脉瘤。
IF 1.5 2区 医学 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2026-01-15 DOI: 10.1177/15266028251413534
Marta Ascione, Rocco Cangiano, Ada Dajci, Alessia Di Girolamo, Francesca Miceli, Andrea Molinari, Antonio Marzano, Luca di Marzo, Wassim Mansour

Purpose: To delineate the strategic approach of the renal branches x-crossing technique in enhancing endovascular treatment of thoracoabdominal (TAAA) and pararenal aortic aneurysms (PAA) using off-the-shelf T-Branch endograft.

Technique: A 72-year-old woman treated with urgent branched endovascular aneurysm repair (BEVAR) because of symptomatic type II thoracoabdominal aortic aneurysm (TAAA). The patient presented complex iliac and renal anatomy, with both renal arteries (RAAs) in upward takeoff, making cannulation from the respective renal branches impossible. In this case, the renal branches x-crossing technique was adopted to address that challenge, and after the deployment of the T-Branch, the cannulation of each renal artery (RA) became from the opposite renal branch, using an axillary access. To get better accommodation in RAAs, we used a self-expandable stent graft on both sides. This technique integrates procedural maneuvers and graft accommodations to ensure effective cannulation, especially in hostile renal artery configurations.

Conclusion: The renal branches' x-crossing technique using a T-Branch endograft seems to be feasible and allows better cannulation of hostile RAAs.Clinical ImpactTo outline the strategic approach of the renal branches x-crossing technique, improving the complex endovascular treatment in hostile aortic morphology using an off-the-shelf T-Branch endograft.

目的:探讨肾支x线交叉技术在胸腹主动脉瘤(TAAA)和肾旁主动脉瘤(PAA)血管内移植治疗中的应用策略。技术:一名72岁女性因症状型胸腹主动脉瘤(TAAA)接受紧急支状血管内动脉瘤修复(BEVAR)治疗。患者髂和肾解剖结构复杂,双肾动脉(RAAs)向上起飞,无法从各自的肾分支插管。在这种情况下,采用肾分支x线交叉技术来解决这一挑战,在t分支部署后,每条肾动脉(RA)的插管从对面的肾分支开始,使用腋窝通道。为了在raa中获得更好的调节,我们在两侧使用了自膨胀支架。该技术结合了手术操作和移植物调节,以确保有效的插管,特别是在不利的肾动脉配置中。结论:采用t支内移植物的肾分支x线交叉技术是可行的,可以更好地对不良RAAs进行插管。临床影响概述肾支x线交叉技术的策略方法,改进使用现成的t支血管内移植物在不良主动脉形态的复杂血管内治疗。
{"title":"Renal Revascularization With X-Crossing Technique During Complex Aortic Aneurysm Repair Using Branched Endograft.","authors":"Marta Ascione, Rocco Cangiano, Ada Dajci, Alessia Di Girolamo, Francesca Miceli, Andrea Molinari, Antonio Marzano, Luca di Marzo, Wassim Mansour","doi":"10.1177/15266028251413534","DOIUrl":"https://doi.org/10.1177/15266028251413534","url":null,"abstract":"<p><strong>Purpose: </strong>To delineate the strategic approach of the renal branches x-crossing technique in enhancing endovascular treatment of thoracoabdominal (TAAA) and pararenal aortic aneurysms (PAA) using off-the-shelf T-Branch endograft.</p><p><strong>Technique: </strong>A 72-year-old woman treated with urgent branched endovascular aneurysm repair (BEVAR) because of symptomatic type II thoracoabdominal aortic aneurysm (TAAA). The patient presented complex iliac and renal anatomy, with both renal arteries (RAAs) in upward takeoff, making cannulation from the respective renal branches impossible. In this case, the renal branches x-crossing technique was adopted to address that challenge, and after the deployment of the T-Branch, the cannulation of each renal artery (RA) became from the opposite renal branch, using an axillary access. To get better accommodation in RAAs, we used a self-expandable stent graft on both sides. This technique integrates procedural maneuvers and graft accommodations to ensure effective cannulation, especially in hostile renal artery configurations.</p><p><strong>Conclusion: </strong>The renal branches' x-crossing technique using a T-Branch endograft seems to be feasible and allows better cannulation of hostile RAAs.Clinical ImpactTo outline the strategic approach of the renal branches x-crossing technique, improving the complex endovascular treatment in hostile aortic morphology using an off-the-shelf T-Branch endograft.</p>","PeriodicalId":50210,"journal":{"name":"Journal of Endovascular Therapy","volume":" ","pages":"15266028251413534"},"PeriodicalIF":1.5,"publicationDate":"2026-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145991574","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Covered Endovascular Reconstruction of Aortic Bifurcation (CERAB) Technique for Delayed Post-traumatic Aortocaval Fistula: A Case Report. 有盖主动脉分叉血管内重建(CERAB)技术治疗迟发性创伤后主动脉腔瘘1例报告。
IF 1.5 2区 医学 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2026-01-15 DOI: 10.1177/15266028251388735
Mohammed Noureldin, Mohamed Hassan, Amro El Okda

Purpose: To report a rare entity and its management that occurred at our facility: delayed traumatic aortocaval fistula with resultant cardiac, renal, and lower limbs symptoms.

Case report: A 25-year-old man with history of gunshot injury and abdominal exploration 7 years ago presented with signs of congestive heart failure, high pulse pressure, right lower limb edema, and audible bruit with felt thrill with dilated veins in the anterior abdominal wall and groin. After full physical examination and imaging studies, computed tomographic angiography confirmed the diagnosis of distal aortocaval fistula, and treatment was endovascular fistula repair using covered endovascular reconstruction of aortic bifurcation (CERAB) technique. Treatment outcome was satisfactory with significant improvement of cardiac, abdominal, and peripheral manifestations 10 days after the procedure.

Conclusion: This case demonstrates that endovascular management of distal aortocaval fistulas using CERAB technique is safe and effective.Clincal ImpactThis is the first reported case of delayed post traumatic Aorti-caval fistula has been managed using covered endovascular reconstruction of aortic bifurcation technique.

目的:报告一例发生在本院的罕见病例及其处理:迟发性外伤性主动脉腔静脉瘘伴心脏、肾脏和下肢症状。病例报告:25岁男性,7年前有枪伤和腹部探查史,表现为充血性心力衰竭,脉压高,右下肢水肿,听得见杂音伴震颤感,前腹壁和腹股沟静脉扩张。经过充分的体格检查和影像学检查,计算机断层血管造影证实诊断为主动脉下腔远端瘘,治疗采用覆盖主动脉分叉血管内重建(CERAB)技术进行血管内瘘修复。治疗结果令人满意,术后10天心脏、腹部和外周表现明显改善。结论:本病例证明CERAB技术对主动脉下腔远端瘘的血管内治疗是安全有效的。临床影响:这是第一例使用覆盖主动脉分叉血管内重建技术治疗的延迟性创伤后主动脉-腔静脉瘘。
{"title":"Covered Endovascular Reconstruction of Aortic Bifurcation (CERAB) Technique for Delayed Post-traumatic Aortocaval Fistula: A Case Report.","authors":"Mohammed Noureldin, Mohamed Hassan, Amro El Okda","doi":"10.1177/15266028251388735","DOIUrl":"https://doi.org/10.1177/15266028251388735","url":null,"abstract":"<p><strong>Purpose: </strong>To report a rare entity and its management that occurred at our facility: delayed traumatic aortocaval fistula with resultant cardiac, renal, and lower limbs symptoms.</p><p><strong>Case report: </strong>A 25-year-old man with history of gunshot injury and abdominal exploration 7 years ago presented with signs of congestive heart failure, high pulse pressure, right lower limb edema, and audible bruit with felt thrill with dilated veins in the anterior abdominal wall and groin. After full physical examination and imaging studies, computed tomographic angiography confirmed the diagnosis of distal aortocaval fistula, and treatment was endovascular fistula repair using covered endovascular reconstruction of aortic bifurcation (CERAB) technique. Treatment outcome was satisfactory with significant improvement of cardiac, abdominal, and peripheral manifestations 10 days after the procedure.</p><p><strong>Conclusion: </strong>This case demonstrates that endovascular management of distal aortocaval fistulas using CERAB technique is safe and effective.Clincal ImpactThis is the first reported case of delayed post traumatic Aorti-caval fistula has been managed using covered endovascular reconstruction of aortic bifurcation technique.</p>","PeriodicalId":50210,"journal":{"name":"Journal of Endovascular Therapy","volume":" ","pages":"15266028251388735"},"PeriodicalIF":1.5,"publicationDate":"2026-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145991598","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Novel Surgical Software Tool to Improve the Physician-Modified Endograft Workflow. 一种新的外科软件工具,以改善医生修改的内移植物工作流程。
IF 1.5 2区 医学 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2026-01-12 DOI: 10.1177/15266028251406185
Bendegúz Juhos, András Szentiványi, Ákos Bérczi, Artúr Hüttl, Sarolta Borzsák, Fanni Szablics, Péter Osztrogonácz, Judit Csőre, Csaba Csobay-Novák

Objective: Three-dimensional models are increasingly used to facilitate the positioning of fenestrations on a physician-modified endograft (PMEG) during the fenestrated endovascular aortic repair (FEVAR) of complex abdominal aortic aneurysms (CAAA). The punch card technique was developed to eliminate the 3D printing workflow while preserving the benefits of having a 3D model. The objective of the current study is to evaluate the performance of the purpose-built software EndoDraft compared to manual punch card design.

Methods: An experimental study was performed to compare software-assisted and manual punch card creation. Fenestration data of readily available procedural plans were used for patients who underwent elective FEVAR for CAAA from May 2023 to September 2024. Time needed to complete punch card planning was recorded as well as inaccuracies of the manual technique were evaluated by measuring the vertical and circumferential position of the fenestrations on the punch card.

Results: A total of 76 punch cards and 288 fenestrations were made based on 38 patients' fenestration data. Preparation time was 233.0 ± 40.3 seconds for the manual group, whereas 63.2 ± 21.5 seconds for the software-aided group (p<0.001). Longitudinal imprecision of the manual punch card was 0.8 ± 0.6 mm for the celiac axis (CA), 1.0 ± 0.6 mm for the superior mesenteric artery (SMA), 0.8 ± 0.5 mm for the right renal artery (RRen), whereas 1.0 ± 0.6 mm for the left renal artery (LRen). Circumferential errors of the same fenestrations were 0.4 ± 0.4 mm for the CA, 0.4 ± 0.4 mm for the SMA, 0.6 ± 0.5 mm for the RRen, and 0.5 ± 0.4 mm for the LRen. No significant difference between the completion time recorded at the beginning and at the end of the software's learning curve was detected (77.8 ± 29.4 s vs 55.8 ± 18.5 s, p=0.15).

Conclusions: The software-assisted design of the punch card is associated with higher precision and a vast improvement in speed compared to the manual technique during PMEG planning for the endovascular treatment of CAAAs. The purpose-built EndoDraft tool was made freely available in an online repository offering a more streamlined workflow.Clinical ImpactEndoDraft® could meaningfully streamline the PMEG-FEVAR workflow by replacing manual punch-card drafting with rapid, software-generated, proportionally scaled templates that are produced in about one minute rather than several minutes, while reducing the small but measurable positioning errors inherent to hand drawing. For clinicians, this means a more reproducible planning step, less cognitive load and "ruler time" during preparation, and a workflow that is easier to standardize across operators with a short learning curve. The key innovation is purpose-built automation with integrated 2D/virtual 3D visualization and direct PDF output, made freely available to support wider adoption.

目的:在复杂腹主动脉瘤(CAAA)开窗血管内主动脉修复(FEVAR)中,三维模型越来越多地用于医生改良的腔内移植物(PMEG)上的开窗定位。打孔卡技术的开发是为了消除3D打印工作流程,同时保留具有3D模型的好处。当前研究的目的是评估专用软件EndoDraft与手动打孔卡设计的性能。方法:对软件辅助和手工打孔卡制作进行了实验研究。对2023年5月至2024年9月因CAAA而进行选择性FEVAR的患者,采用现成的手术计划的开窗数据。记录完成穿孔卡规划所需的时间,并通过测量穿孔卡上开窗的垂直和圆周位置来评估手工技术的不准确性。结果:根据38例患者的开窗数据,共制作76张打孔卡和288个开窗。手工组的准备时间为233.0±40.3秒,而软件辅助组的准备时间为63.2±21.5秒。结论:与手工技术相比,软件辅助设计的打孔卡在动脉粥样硬化血管内治疗的PMEG计划中具有更高的精度和速度上的巨大提高。专门构建的EndoDraft工具在在线存储库中免费提供,提供更简化的工作流程。临床ImpactEndoDraft®可以有效地简化PMEG-FEVAR工作流程,用快速、软件生成、按比例缩放的模板取代人工打孔卡制图,这些模板在一分钟内生成,而不是几分钟,同时减少手绘固有的小但可测量的定位误差。对于临床医生来说,这意味着更可重复的计划步骤,更少的认知负荷和准备过程中的“标尺时间”,以及更容易标准化的工作流程,并且学习曲线短。关键的创新是集成2D/虚拟3D可视化和直接PDF输出的专用自动化,免费提供以支持更广泛的采用。
{"title":"A Novel Surgical Software Tool to Improve the Physician-Modified Endograft Workflow.","authors":"Bendegúz Juhos, András Szentiványi, Ákos Bérczi, Artúr Hüttl, Sarolta Borzsák, Fanni Szablics, Péter Osztrogonácz, Judit Csőre, Csaba Csobay-Novák","doi":"10.1177/15266028251406185","DOIUrl":"https://doi.org/10.1177/15266028251406185","url":null,"abstract":"<p><strong>Objective: </strong>Three-dimensional models are increasingly used to facilitate the positioning of fenestrations on a physician-modified endograft (PMEG) during the fenestrated endovascular aortic repair (FEVAR) of complex abdominal aortic aneurysms (CAAA). The punch card technique was developed to eliminate the 3D printing workflow while preserving the benefits of having a 3D model. The objective of the current study is to evaluate the performance of the purpose-built software EndoDraft compared to manual punch card design.</p><p><strong>Methods: </strong>An experimental study was performed to compare software-assisted and manual punch card creation. Fenestration data of readily available procedural plans were used for patients who underwent elective FEVAR for CAAA from May 2023 to September 2024. Time needed to complete punch card planning was recorded as well as inaccuracies of the manual technique were evaluated by measuring the vertical and circumferential position of the fenestrations on the punch card.</p><p><strong>Results: </strong>A total of 76 punch cards and 288 fenestrations were made based on 38 patients' fenestration data. Preparation time was 233.0 ± 40.3 seconds for the manual group, whereas 63.2 ± 21.5 seconds for the software-aided group (p<0.001). Longitudinal imprecision of the manual punch card was 0.8 ± 0.6 mm for the celiac axis (CA), 1.0 ± 0.6 mm for the superior mesenteric artery (SMA), 0.8 ± 0.5 mm for the right renal artery (RRen), whereas 1.0 ± 0.6 mm for the left renal artery (LRen). Circumferential errors of the same fenestrations were 0.4 ± 0.4 mm for the CA, 0.4 ± 0.4 mm for the SMA, 0.6 ± 0.5 mm for the RRen, and 0.5 ± 0.4 mm for the LRen. No significant difference between the completion time recorded at the beginning and at the end of the software's learning curve was detected (77.8 ± 29.4 s vs 55.8 ± 18.5 s, p=0.15).</p><p><strong>Conclusions: </strong>The software-assisted design of the punch card is associated with higher precision and a vast improvement in speed compared to the manual technique during PMEG planning for the endovascular treatment of CAAAs. The purpose-built EndoDraft tool was made freely available in an online repository offering a more streamlined workflow.Clinical ImpactEndoDraft® could meaningfully streamline the PMEG-FEVAR workflow by replacing manual punch-card drafting with rapid, software-generated, proportionally scaled templates that are produced in about one minute rather than several minutes, while reducing the small but measurable positioning errors inherent to hand drawing. For clinicians, this means a more reproducible planning step, less cognitive load and \"ruler time\" during preparation, and a workflow that is easier to standardize across operators with a short learning curve. The key innovation is purpose-built automation with integrated 2D/virtual 3D visualization and direct PDF output, made freely available to support wider adoption.</p>","PeriodicalId":50210,"journal":{"name":"Journal of Endovascular Therapy","volume":" ","pages":"15266028251406185"},"PeriodicalIF":1.5,"publicationDate":"2026-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145959359","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mid-Term Outcomes of PTFE-Based Contralateral Iliac Limbs in Polyester-Based Fenestrated Bifurcated Endografts. ptfe基对侧髂肢体在聚酯基开孔分叉内移植物中的中期结果。
IF 1.5 2区 医学 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2026-01-10 DOI: 10.1177/15266028251409061
Kalliopi-Maria Tasopoulou, Angelos Karelis, Wendela Jirström, Yasir Mohammed, Márton Berczeli, Umar Sadat, Björn Sonesson, Nuno V Dias

Purpose: The aim of this study was to evaluate the feasibility and mid-term results of combining polytetrafluoroethylene (PTFE)-based iliac limbs, having a short dilator tip, with a polyester (Dacron)-based bifurcated component during a fenestrated endovascular aortic repair (FEVAR).

Materials and methods: All patients who underwent a FEVAR procedure in a single tertiary center were screened for inclusion in the study. Data were collected retrospectively and all imaging was reviewed for the study. The criterion for inclusion in the study was the implantation of a PTFE-based iliac limb endoprosthesis at the contralateral side of the polyester-based bifurcated component during a FEVAR procedure landing in a native common iliac artery. The primary study endpoints were technical success, adverse events, and reinterventions related to limbs, migration between contralateral iliac limbs and bifurcated components, type Ib and IIIa endoleaks, and iliac limb patency.

Results: A total of 30 patients with a median age of 77 (70, 79) years, who underwent FEVAR procedures from June 2020 to July 2023, were included in the study. The total number of target vessels was 116, and the majority (N = 24) of patients received 4 fenestrations. Technical success was achieved for the iliac limb in all patients, and for the FEVAR, it was obtained in 29 cases (97%). Median follow-up was 24 (12, 30) months. There were no clinical limb-related adverse events or reinterventions. At the end of the follow-up period, all limbs remained patent. The median absolute and percentual change in overlap between the limb and the cuff of the bifurcated endograft was of -0.1 mm (-0.8, 1.1) and -0.4% (-2.7, 4), respectively. The estimated primary, secondary clinical success of the FEVAR, and survival rates (± standard error) at 2 years were 86 ±7%, 90±6, and 83±7%, respectively.

Conclusions: The present study demonstrated promising mid-term outcomes, with the absence of limb-related adverse events, reinterventions, and any significant change in the overlap of PTFE iliac limbs combined with polyester bifurcated device during FEVAR. Further validation in a larger cohort as well as comparative analysis between different component combinations are needed to confirm the findings of the present study.Clinical ImpactThis study underscores the feasibility and excellent mid-term clinical outcomes of combining PTFE-based iliac limbs with a short dilator tip and a polyester-based bifurcated component during fenestrated endovascular aortic repair. The absence of significant migration and adverse effects related to the iliac limbs, along with the lack of target vessel occlusions, suggests a potential advantage of using a delivery system that avoids crossing the fenestrations, thereby enhancing technical success and ensuring stable and durable results over time.

目的:本研究的目的是评估在开窗血管内主动脉修复(FEVAR)中,将具有短扩张器尖端的聚四氟乙烯(PTFE)基髂肢与聚酯(涤纶)基分叉部件联合使用的可行性和中期结果。材料和方法:所有在单一三级中心接受FEVAR手术的患者均被筛选纳入研究。回顾性收集资料并回顾所有影像学资料。纳入研究的标准是在FEVAR手术过程中,在原髂总动脉着落的聚酯基分叉部件的对侧植入ptfe基髂肢体内假体。主要研究终点是技术成功、不良事件和与肢体相关的再干预、对侧髂肢体和分叉部件之间的迁移、Ib型和IIIa型内漏以及髂肢体通畅。结果:共有30例患者在2020年6月至2023年7月期间接受了FEVAR手术,中位年龄为77(70,79)岁。靶血管总数为116条,多数患者(N = 24)接受4次开窗。所有患者的髂肢体均获得了技术成功,而FEVAR在29例(97%)中获得了技术成功。中位随访时间为24(12,30)个月。没有与肢体相关的临床不良事件或再干预。在随访期结束时,所有肢体均保持正常。分支内移植物的肢体和袖带重叠的绝对和百分比变化的中位数分别为-0.1 mm(-0.8, 1.1)和-0.4%(-2.7,4)。估计FEVAR的原发性、继发性临床成功率和2年生存率(±标准误差)分别为86±7%、90±6%和83±7%。结论:本研究显示了有希望的中期结果,在FEVAR期间,没有肢体相关的不良事件,没有再干预,PTFE髂骨肢体与聚酯分叉装置的重叠没有任何显著变化。需要在更大的队列中进一步验证以及不同成分组合之间的比较分析来证实本研究的结果。临床影响本研究强调了ptfe为基础的髂肢与短扩张器尖端和聚酯为基础的分叉部件在开腔血管内主动脉修复中的可行性和良好的中期临床效果。由于没有明显的移位和与髂肢相关的不良反应,以及缺乏靶血管闭塞,表明使用避免穿过开窗的输送系统具有潜在的优势,从而提高技术成功率,并确保长期稳定和持久的结果。
{"title":"Mid-Term Outcomes of PTFE-Based Contralateral Iliac Limbs in Polyester-Based Fenestrated Bifurcated Endografts.","authors":"Kalliopi-Maria Tasopoulou, Angelos Karelis, Wendela Jirström, Yasir Mohammed, Márton Berczeli, Umar Sadat, Björn Sonesson, Nuno V Dias","doi":"10.1177/15266028251409061","DOIUrl":"https://doi.org/10.1177/15266028251409061","url":null,"abstract":"<p><strong>Purpose: </strong>The aim of this study was to evaluate the feasibility and mid-term results of combining polytetrafluoroethylene (PTFE)-based iliac limbs, having a short dilator tip, with a polyester (Dacron)-based bifurcated component during a fenestrated endovascular aortic repair (FEVAR).</p><p><strong>Materials and methods: </strong>All patients who underwent a FEVAR procedure in a single tertiary center were screened for inclusion in the study. Data were collected retrospectively and all imaging was reviewed for the study. The criterion for inclusion in the study was the implantation of a PTFE-based iliac limb endoprosthesis at the contralateral side of the polyester-based bifurcated component during a FEVAR procedure landing in a native common iliac artery. The primary study endpoints were technical success, adverse events, and reinterventions related to limbs, migration between contralateral iliac limbs and bifurcated components, type Ib and IIIa endoleaks, and iliac limb patency.</p><p><strong>Results: </strong>A total of 30 patients with a median age of 77 (70, 79) years, who underwent FEVAR procedures from June 2020 to July 2023, were included in the study. The total number of target vessels was 116, and the majority (N = 24) of patients received 4 fenestrations. Technical success was achieved for the iliac limb in all patients, and for the FEVAR, it was obtained in 29 cases (97%). Median follow-up was 24 (12, 30) months. There were no clinical limb-related adverse events or reinterventions. At the end of the follow-up period, all limbs remained patent. The median absolute and percentual change in overlap between the limb and the cuff of the bifurcated endograft was of -0.1 mm (-0.8, 1.1) and -0.4% (-2.7, 4), respectively. The estimated primary, secondary clinical success of the FEVAR, and survival rates (± standard error) at 2 years were 86 ±7%, 90±6, and 83±7%, respectively.</p><p><strong>Conclusions: </strong>The present study demonstrated promising mid-term outcomes, with the absence of limb-related adverse events, reinterventions, and any significant change in the overlap of PTFE iliac limbs combined with polyester bifurcated device during FEVAR. Further validation in a larger cohort as well as comparative analysis between different component combinations are needed to confirm the findings of the present study.Clinical ImpactThis study underscores the feasibility and excellent mid-term clinical outcomes of combining PTFE-based iliac limbs with a short dilator tip and a polyester-based bifurcated component during fenestrated endovascular aortic repair. The absence of significant migration and adverse effects related to the iliac limbs, along with the lack of target vessel occlusions, suggests a potential advantage of using a delivery system that avoids crossing the fenestrations, thereby enhancing technical success and ensuring stable and durable results over time.</p>","PeriodicalId":50210,"journal":{"name":"Journal of Endovascular Therapy","volume":" ","pages":"15266028251409061"},"PeriodicalIF":1.5,"publicationDate":"2026-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145949515","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pedal Medial Arterial Calcification and Its Impact on Wound Healing in Patients With Chronic Limb-Threatening Ischemia After Inframalleolar Revascularization. 足内侧动脉钙化及其对踝下血管重建术后慢性肢体缺血患者伤口愈合的影响。
IF 1.5 2区 医学 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2026-01-10 DOI: 10.1177/15266028251410788
Yosuke Hata, Shin Okamoto, Kiyonori Nanto, Takuya Tsujimura, Sho Nakao, Masaya Kusuda, Wataru Ariyasu, Toshiaki Mano

Background: Pedal medial arterial calcification (pMAC) has been reported as a predictor of poor clinical outcomes in patients with chronic limb-threatening ischemia (CLTI). However, the impact of pMAC in patients with CLTI undergoing endovascular therapy (EVT) for inframalleolar (IM) lesions has not been investigated.

Methods: We retrospectively analyzed 365 patients with CLTI and tissue loss undergoing EVT to IM lesions between April 2010 and December 2020. Pedal medial arterial calcification in foot arteries was assessed radiologically using dorsoplantar and lateral views. The pMAC score was determined as the sum of the presence of pMAC at the following sites: (1) dorsalis pedis, (2) lateral plantar, (3) first metatarsal, (4) first toe, and (5) other toe arteries. The severity of pMAC was classified into 3 groups: no pMAC (0-1 point), moderate pMAC (2-3 points), and severe pMAC (4-5 points). The primary outcome was the 1-year cumulative incidence of wound healing, analyzed using the Kaplan-Meier analysis. Predictors of wound healing were explored using a Cox regression model.

Results: One-year cumulative incidences of wound healing were 68.1%, 39.2%, and 36.7% in patients with no, moderate, and severe pMAC, respectively (log-rank p<0.001). In multivariate analysis, serum albumin < 3.0 g/dL (hazard ratio [HR] = 0.58; 95% confidence interval [CI] = 0.40, 0.86; p=0.006) and severity of pMAC (HR=0.68; 95% CI=0.52, 0.88; p=0.004, per 1-grade increase) were identified as independent predictors of wound healing.

Conclusion: Pedal medial arterial calcification was significantly associated with wound healing in CLTI patients undergoing EVT for IM lesions.Clinical ImpactThe results of this study indicated that pedal medial arterial calcification (pMAC) was significantly associated with wound healing and major amputation in patients with chronic limb-threatening ischemia (CLTI) who underwent EVT for IM lesions. As pMAC can be assessed using only radiography, it may serve as a practical tool for risk stratification prior to revascularization procedures, aiding in treatment decisions based on wound severity. For cases with severe wounds, timely decisions regarding major amputation or a transition to palliative care may be warranted. In contrast, for cases with less severe wounds, early initiation of adjunctive therapies or intensive foot care should be considered.

背景:踏板内侧动脉钙化(pMAC)已被报道为慢性肢体威胁缺血(CLTI)患者不良临床结果的预测因子。然而,pMAC对接受血管内治疗(EVT)治疗踝下(IM)病变的CLTI患者的影响尚未研究。方法:我们回顾性分析了2010年4月至2020年12月期间365例CLTI和组织丢失患者对IM病变进行EVT。脚底内侧动脉钙化在足动脉的放射学评估使用背足底和侧位视图。pMAC评分为以下部位pMAC存在的总和:(1)足背,(2)足底外侧,(3)第一跖,(4)第一脚趾,(5)其他脚趾动脉。pMAC严重程度分为无pMAC(0-1分)、中度pMAC(2-3分)、重度pMAC(4-5分)3组。主要终点为1年累计伤口愈合发生率,采用Kaplan-Meier分析。采用Cox回归模型探讨伤口愈合的预测因素。结果:无pMAC、中度、重度pMAC患者1年累计伤口愈合发生率分别为68.1%、39.2%、36.7% (logrank p)。结论:行EVT治疗IM病变的CLTI患者,足内侧动脉钙化与伤口愈合显著相关。临床影响本研究结果表明,慢性肢体威胁性缺血(CLTI)患者行EVT治疗IM病变后,足部内侧动脉钙化(pMAC)与伤口愈合和主要截肢显著相关。由于pMAC可以仅通过x线摄影进行评估,因此它可以作为血运重建术前风险分层的实用工具,有助于根据伤口严重程度做出治疗决策。对于严重伤口的病例,可能需要及时决定是否进行大截肢或过渡到姑息治疗。相反,对于创伤较轻的病例,应考虑尽早开始辅助治疗或加强足部护理。
{"title":"Pedal Medial Arterial Calcification and Its Impact on Wound Healing in Patients With Chronic Limb-Threatening Ischemia After Inframalleolar Revascularization.","authors":"Yosuke Hata, Shin Okamoto, Kiyonori Nanto, Takuya Tsujimura, Sho Nakao, Masaya Kusuda, Wataru Ariyasu, Toshiaki Mano","doi":"10.1177/15266028251410788","DOIUrl":"https://doi.org/10.1177/15266028251410788","url":null,"abstract":"<p><strong>Background: </strong>Pedal medial arterial calcification (pMAC) has been reported as a predictor of poor clinical outcomes in patients with chronic limb-threatening ischemia (CLTI). However, the impact of pMAC in patients with CLTI undergoing endovascular therapy (EVT) for inframalleolar (IM) lesions has not been investigated.</p><p><strong>Methods: </strong>We retrospectively analyzed 365 patients with CLTI and tissue loss undergoing EVT to IM lesions between April 2010 and December 2020. Pedal medial arterial calcification in foot arteries was assessed radiologically using dorsoplantar and lateral views. The pMAC score was determined as the sum of the presence of pMAC at the following sites: (1) dorsalis pedis, (2) lateral plantar, (3) first metatarsal, (4) first toe, and (5) other toe arteries. The severity of pMAC was classified into 3 groups: no pMAC (0-1 point), moderate pMAC (2-3 points), and severe pMAC (4-5 points). The primary outcome was the 1-year cumulative incidence of wound healing, analyzed using the Kaplan-Meier analysis. Predictors of wound healing were explored using a Cox regression model.</p><p><strong>Results: </strong>One-year cumulative incidences of wound healing were 68.1%, 39.2%, and 36.7% in patients with no, moderate, and severe pMAC, respectively (log-rank p<0.001). In multivariate analysis, serum albumin < 3.0 g/dL (hazard ratio [HR] = 0.58; 95% confidence interval [CI] = 0.40, 0.86; p=0.006) and severity of pMAC (HR=0.68; 95% CI=0.52, 0.88; p=0.004, per 1-grade increase) were identified as independent predictors of wound healing.</p><p><strong>Conclusion: </strong>Pedal medial arterial calcification was significantly associated with wound healing in CLTI patients undergoing EVT for IM lesions.Clinical ImpactThe results of this study indicated that pedal medial arterial calcification (pMAC) was significantly associated with wound healing and major amputation in patients with chronic limb-threatening ischemia (CLTI) who underwent EVT for IM lesions. As pMAC can be assessed using only radiography, it may serve as a practical tool for risk stratification prior to revascularization procedures, aiding in treatment decisions based on wound severity. For cases with severe wounds, timely decisions regarding major amputation or a transition to palliative care may be warranted. In contrast, for cases with less severe wounds, early initiation of adjunctive therapies or intensive foot care should be considered.</p>","PeriodicalId":50210,"journal":{"name":"Journal of Endovascular Therapy","volume":" ","pages":"15266028251410788"},"PeriodicalIF":1.5,"publicationDate":"2026-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145948564","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Balloon-Assisted n-Butyl Cyanoacrylate Filling of Saccular Portal and Splenic Vein Pseudoaneurysms. 球囊辅助氰基丙烯酸丁酯填充囊状门静脉和脾静脉假性动脉瘤。
IF 1.5 2区 医学 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2026-01-10 DOI: 10.1177/15266028251409077
Eisuke Shibata, Hidemasa Takao, Nobuhisa Akamatsu, Kiyoshi Hasegawa, Osamu Abe

Purpose: This report describes endovascular treatment of saccular portal and splenic vein pseudoaneurysms using n-butyl-2-cyanoacrylate (nBCA) with balloon assistance.

Case report: The first case was a 39-year-old female who developed a gastric ulcer after undergoing living-donor liver transplantation (LDLT) due to liver failure following surgery for congenital biliary atresia. Two saccular pseudoaneurysms were developed in the main trunk of the splenic vein, caused by the gastric ulcer, and protruded into the stomach. The second case was a 43-year-old male who presented with a saccular pseudoaneurysm in the main portal vein after LDLT. Because these pseudoaneurysms caused severe hemorrhage in both cases, endovascular treatments were performed via the transhepatic approach in the first case and via the ileocolic approach in the second case. Each pseudoaneurysm was successfully packed with 50% nBCA under balloon-assisted flow control, while preserving the parent veins.

Conclusion: Balloon-assisted nBCA filling of saccular portal venous system pseudoaneurysms is an effective endovascular treatment that can preserve blood flow in parent veins. This technique could become a treatment option, especially when surgery or stent graft placement is difficult for clinical or technical reasons or due to limited stent availability.Clinical ImpactThis report presents an alternative endovascular method for embolizing portal venous system pseudoaneurysms while preserving parent veins. This approach, consisting of nBCA filling with balloon-assisted flow control, offers an alternative to stent graft or covered stent placement. Balloon-assisted nBCA filling can become a viable treatment option for saccular portal venous system pseudoaneurysms, particularly when surgery or stent graft placement is difficult for clinical or technical reasons, or due to limited stent availability.

目的:本报告描述了球囊辅助下应用正丁基-2-氰基丙烯酸酯(nBCA)血管内治疗囊状门脉和脾静脉假性动脉瘤。病例报告:第一位病例是一名39岁的女性,她在先天性胆道闭锁手术后因肝功能衰竭而接受活体肝移植(LDLT)后发生胃溃疡。脾静脉主干由胃溃疡引起,出现2个囊状假性动脉瘤,并向胃内突出。第二例患者为43岁男性,LDLT术后门静脉主干出现囊状假性动脉瘤。由于这两例假性动脉瘤均引起严重出血,故第一例经肝入路,第二例经回结肠入路行血管内治疗。在球囊辅助流量控制下,每个假性动脉瘤成功填充50% nBCA,同时保留母静脉。结论:球囊辅助nBCA填充治疗囊状门静脉系统假性动脉瘤是一种有效的血管内治疗方法,可保持母静脉血流。这项技术可以成为一种治疗选择,特别是当手术或支架植入由于临床或技术原因或由于支架可用性有限而难以放置时。临床影响本报告提出了一种血管内栓塞门静脉系统假性动脉瘤的替代方法,同时保留了母静脉。该方法由球囊辅助流量控制的nBCA填充组成,提供了支架移植或覆盖支架放置的替代方案。球囊辅助nBCA填充可以成为囊状门静脉系统假性动脉瘤的可行治疗选择,特别是当手术或支架植入由于临床或技术原因或由于支架可用性有限而难以放置时。
{"title":"Balloon-Assisted <i>n</i>-Butyl Cyanoacrylate Filling of Saccular Portal and Splenic Vein Pseudoaneurysms.","authors":"Eisuke Shibata, Hidemasa Takao, Nobuhisa Akamatsu, Kiyoshi Hasegawa, Osamu Abe","doi":"10.1177/15266028251409077","DOIUrl":"https://doi.org/10.1177/15266028251409077","url":null,"abstract":"<p><strong>Purpose: </strong>This report describes endovascular treatment of saccular portal and splenic vein pseudoaneurysms using <i>n</i>-butyl-2-cyanoacrylate (nBCA) with balloon assistance.</p><p><strong>Case report: </strong>The first case was a 39-year-old female who developed a gastric ulcer after undergoing living-donor liver transplantation (LDLT) due to liver failure following surgery for congenital biliary atresia. Two saccular pseudoaneurysms were developed in the main trunk of the splenic vein, caused by the gastric ulcer, and protruded into the stomach. The second case was a 43-year-old male who presented with a saccular pseudoaneurysm in the main portal vein after LDLT. Because these pseudoaneurysms caused severe hemorrhage in both cases, endovascular treatments were performed via the transhepatic approach in the first case and via the ileocolic approach in the second case. Each pseudoaneurysm was successfully packed with 50% nBCA under balloon-assisted flow control, while preserving the parent veins.</p><p><strong>Conclusion: </strong>Balloon-assisted nBCA filling of saccular portal venous system pseudoaneurysms is an effective endovascular treatment that can preserve blood flow in parent veins. This technique could become a treatment option, especially when surgery or stent graft placement is difficult for clinical or technical reasons or due to limited stent availability.Clinical ImpactThis report presents an alternative endovascular method for embolizing portal venous system pseudoaneurysms while preserving parent veins. This approach, consisting of nBCA filling with balloon-assisted flow control, offers an alternative to stent graft or covered stent placement. Balloon-assisted nBCA filling can become a viable treatment option for saccular portal venous system pseudoaneurysms, particularly when surgery or stent graft placement is difficult for clinical or technical reasons, or due to limited stent availability.</p>","PeriodicalId":50210,"journal":{"name":"Journal of Endovascular Therapy","volume":" ","pages":"15266028251409077"},"PeriodicalIF":1.5,"publicationDate":"2026-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145949423","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Aortic Valve Crimper Technique Reduces Reloading Time Compared With the Tourniquet Method in Physician-Modified Endograft Preparation. 与止血带方法相比,主动脉瓣卷曲器技术在医生改良的血管内移植物制备中减少了重装时间。
IF 1.5 2区 医学 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2026-01-08 DOI: 10.1177/15266028251412797
Peter Osztrogonacz, Judit Csőre, Artúr Hüttl, Ákos Bérczi, András Szentiványi, Csaba Csobay-Novák

Objective: Physician-modified endografts (PMEGs) are increasingly used for urgent or off-label repair of complex abdominal aortic aneurysms (AAAs) when custom-made devices are unavailable. A key technical step in PMEG preparation is reloading of the modified stent graft into its original delivery system. Aortic valve stent crimpers have recently been repurposed to assist in reloading, but direct comparisons are lacking with the traditional tourniquet technique. This study aims to compare the efficiency and reliability of tourniquet- and crimper-assisted reloading in a controlled benchtop setting.

Methods: Eighteen reloading procedures were performed using a Medtronic Valiant 38×200 mm thoracic stent graft, with 9 per technique. Trained operators conducted the reloading under standardized conditions. The primary outcome was reloading time. The secondary endpoints included the infolding potential following deployment in simulated aortic models with oversizing conditions of 21%, 34%, and 42%. Postdeployment morphology was assessed by computed tomography (CT) imaging and reviewed by a blinded observer. Continuous data were analyzed using the Mann-Whitney U test and categorical data by Fisher's exact test.

Results: The crimper technique significantly reduced the reloading time compared with the tourniquet method (median 3.98 minutes, interquartile range [IQR=3.27-5.23] vs 11.48 minutes [IQR=8.82-17.35]; p=0.001). No infolding was observed in any of the 18 deployed grafts across all oversizing subgroups. Inadvertent proximal clasp release complicated the tourniquet technique (n=3), while this issue was absent with the crimper (n=0, p=0.206). Device integrity was preserved throughout, although the delivery system required replacement once after repeated reuse.

Conclusion: This benchtop study demonstrates that the crimper technique provides a faster and more consistent alternative to the traditional tourniquet method for PMEG stent graft reloading. The use of an aortic valve crimper may enhance standardization and workflow efficiency, without infolding.Clinical ImpactIn this bench-top comparison of PMEG reloading techniques, a repurposed aortic valve stent crimper outperformed the traditional tourniquet method by reducing reloading time, without an increase in graft infolding. The improved efficiency associated with the crimper technique highlight its potential value as a standardized approach to PMEG preparation, particularly in time-critical scenarios.

目的:在没有定制设备的情况下,医师改良的内移植物(pmeg)越来越多地用于复杂腹主动脉瘤(AAAs)的紧急或超说明书修复。PMEG制备的关键技术步骤是将改良后的支架重新装入其原有的输送系统。主动脉瓣支架卷曲器最近被重新用于协助重新加载,但缺乏与传统止血带技术的直接比较。本研究的目的是比较止血带和卷曲器辅助重装在控制台上设置的效率和可靠性。方法:使用美敦力Valiant 38×200 mm胸椎支架进行了18次再填充手术,每种技术9次。训练有素的操作人员在标准化条件下进行装填。主要结果是重新装填时间。次要终点包括在模拟主动脉模型中部署后的折叠潜力,分别为21%、34%和42%。部署后形态学通过计算机断层扫描(CT)成像进行评估,并由盲法观察者进行审查。连续数据采用Mann-Whitney U检验,分类数据采用Fisher精确检验。结果:与止血带方法相比,卷曲技术显著缩短了重新加载时间(中位数3.98分钟,四分位数间距[IQR=3.27 ~ 5.23] vs . 11.48分钟[IQR=8.82 ~ 17.35]; p=0.001)。在所有超大亚组的18个部署移植物中均未观察到内折叠。不小心近端卡环松开使止血带技术复杂化(n=3),而卷曲器没有这个问题(n=0, p=0.206)。尽管在重复使用后需要更换一次输送系统,但设备的完整性始终保持不变。结论:本实验表明,卷曲技术为PMEG支架再填充提供了一种比传统止血带方法更快、更一致的替代方法。使用主动脉瓣卷曲器可以提高标准化和工作流程效率,而无需折叠。临床影响:在PMEG重装技术的实验比较中,一种改头换面的主动脉瓣支架卷曲器通过减少重装时间而优于传统止血带方法,而不会增加移植物折叠。与卷曲技术相关的效率提高突出了其作为PMEG制备标准化方法的潜在价值,特别是在时间紧迫的情况下。
{"title":"The Aortic Valve Crimper Technique Reduces Reloading Time Compared With the Tourniquet Method in Physician-Modified Endograft Preparation.","authors":"Peter Osztrogonacz, Judit Csőre, Artúr Hüttl, Ákos Bérczi, András Szentiványi, Csaba Csobay-Novák","doi":"10.1177/15266028251412797","DOIUrl":"https://doi.org/10.1177/15266028251412797","url":null,"abstract":"<p><strong>Objective: </strong>Physician-modified endografts (PMEGs) are increasingly used for urgent or off-label repair of complex abdominal aortic aneurysms (AAAs) when custom-made devices are unavailable. A key technical step in PMEG preparation is reloading of the modified stent graft into its original delivery system. Aortic valve stent crimpers have recently been repurposed to assist in reloading, but direct comparisons are lacking with the traditional tourniquet technique. This study aims to compare the efficiency and reliability of tourniquet- and crimper-assisted reloading in a controlled benchtop setting.</p><p><strong>Methods: </strong>Eighteen reloading procedures were performed using a Medtronic Valiant 38×200 mm thoracic stent graft, with 9 per technique. Trained operators conducted the reloading under standardized conditions. The primary outcome was reloading time. The secondary endpoints included the infolding potential following deployment in simulated aortic models with oversizing conditions of 21%, 34%, and 42%. Postdeployment morphology was assessed by computed tomography (CT) imaging and reviewed by a blinded observer. Continuous data were analyzed using the Mann-Whitney <i>U</i> test and categorical data by Fisher's exact test.</p><p><strong>Results: </strong>The crimper technique significantly reduced the reloading time compared with the tourniquet method (median 3.98 minutes, interquartile range [IQR=3.27-5.23] vs 11.48 minutes [IQR=8.82-17.35]; p=0.001). No infolding was observed in any of the 18 deployed grafts across all oversizing subgroups. Inadvertent proximal clasp release complicated the tourniquet technique (n=3), while this issue was absent with the crimper (n=0, p=0.206). Device integrity was preserved throughout, although the delivery system required replacement once after repeated reuse.</p><p><strong>Conclusion: </strong>This benchtop study demonstrates that the crimper technique provides a faster and more consistent alternative to the traditional tourniquet method for PMEG stent graft reloading. The use of an aortic valve crimper may enhance standardization and workflow efficiency, without infolding.Clinical ImpactIn this bench-top comparison of PMEG reloading techniques, a repurposed aortic valve stent crimper outperformed the traditional tourniquet method by reducing reloading time, without an increase in graft infolding. The improved efficiency associated with the crimper technique highlight its potential value as a standardized approach to PMEG preparation, particularly in time-critical scenarios.</p>","PeriodicalId":50210,"journal":{"name":"Journal of Endovascular Therapy","volume":" ","pages":"15266028251412797"},"PeriodicalIF":1.5,"publicationDate":"2026-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145936043","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Physician-Modified Endografts in Elective Care: A Report From the REgistry of MOdified Treo Endografts in Europe (REMOTE). 选择性护理中的医师改良内移植物:来自欧洲改良Treo内移植物登记的报告(远程)。
IF 1.5 2区 医学 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2026-01-08 DOI: 10.1177/15266028251405754
Csaba Csobay-Novák, Carlo Patrizio Dionisi, András Szentiványi, Ákos Bérczi, Péter Osztrogonácz, Angelo Di Sabato, Vaiva Dabravolskaite, Konstantinos Kotopoulos, Thomas R Wyss, Vladimir Makaloski

Objective: Physician-modified endografts (PMEGs) are widely accepted as a viable option in the urgent management of patients with complex abdominal aortic aneurysms (CAAAs). While PMEGs have emerged as the predominant repair modality for CAAAs in the United States, their acceptance in Europe remains limited-particularly in the context of elective repair. The aim of this study was to present the initial experience with elective cases at pioneering European centers offering this treatment.

Methods: This is a retrospective observational study based on an international multicenter registry (REgistry of MOdified Treo endografts in Europe-REMOTE). Data were collected from 4 European centers on patients who underwent elective PMEG repair using the Treo device for CAAAs between August 2023 and February 2025. Demographic characteristics, clinical status, procedural details and follow-up data were recorded. Primary outcomes included technical success, overall and aortic-related mortality, and adverse events.

Results: Twenty-eight patients (20 males; mean age 76.3±6.8 years) underwent elective PMEG repair with the Treo device. Most procedures incorporated at least 3 target vessels (68.3%). The average time required for device modification was 47.4±20.3 minutes. Technical success was achieved in 96.4% of cases. The single technical failure was associated with a lost accessory renal artery, with no acute kidney injury occurred nor endoleak observed. There were no in-hospital deaths or major adverse events. At short-term follow-up (mean 5.9±4.8 months), overall mortality was 3.6% (n=1, non-aortic-related). Freedom from reintervention was 92.9% (n=26). Aneurysm sac shrinkage was observed in 25% of patients (n=7), with the remainder showing stability. Primary and secondary target vessel patency rates were both 98.8% (n=81), with one renal stent occlusion noted on follow-up imaging.

Conclusion: This multicenter retrospective observational study demonstrated that elective PMEG repair of CAAAs using the Treo device is associated with a high-technical-success rate and a low incidence of clinical complications, supporting the safety and feasibility of this approach in the elective setting.Clinical ImpactREMOTE provides a multicentre European snapshot of elective PMEG-FEVAR on a single abdominal platform (Treo), showing high technical success with major clinical complications being uncommon, supporting feasibility in the elective setting. This could change practice by enabling experienced centres to offer a structured elective PMEG pathway and reduce decision-to-operation time from the 1-4 months often seen with CMD logistics to days (or even hours), thereby lowering interval-rupture risk and patient anxiety. For clinicians, this means a more predictable workflow that can shorten the learning curve and broaden access where CMD availability/cost is limiting.

目的:在复杂腹主动脉瘤(CAAAs)患者的紧急治疗中,医师改良的内移植物(PMEGs)被广泛接受为一种可行的选择。虽然pmeg在美国已经成为caaa的主要修复方式,但在欧洲的接受度仍然有限,特别是在选择性修复的背景下。本研究的目的是介绍在开创性的欧洲中心提供这种治疗的选择性病例的初步经验。方法:这是一项基于国际多中心注册(registry of MOdified Treo endografts in Europe-REMOTE)的回顾性观察性研究。数据来自4个欧洲中心,收集了2023年8月至2025年2月期间使用Treo设备进行选择性PMEG修复的caaa患者。记录患者的人口学特征、临床状况、手术细节及随访资料。主要结局包括技术成功、总死亡率和主动脉相关死亡率以及不良事件。结果:28例患者(男性20例,平均年龄76.3±6.8岁)采用Treo装置进行选择性PMEG修复。大多数手术至少包含3条靶血管(68.3%)。器械修改的平均时间为47.4±20.3 min。96.4%的病例技术成功率。单一技术故障与肾副动脉丢失有关,未发生急性肾损伤,也未观察到肾渗漏。没有院内死亡或重大不良事件。在短期随访中(平均5.9±4.8个月),总死亡率为3.6% (n=1,非主动脉相关)。再干预自由度为92.9% (n=26)。25%的患者(n=7)观察到动脉瘤囊收缩,其余患者表现稳定。原发性和继发性靶血管通畅率均为98.8% (n=81),随访影像学显示有一例肾支架闭塞。结论:本多中心回顾性观察研究表明,使用Treo装置选择性PMEG修复CAAAs具有高技术成功率和低临床并发症发生率,支持该方法在选择性环境下的安全性和可行性。临床ImpactREMOTE在单一腹部平台(Treo)上提供了选择性PMEG-FEVAR的多中心欧洲快照,显示了高技术成功,主要临床并发症罕见,支持选择性设置的可行性。这可能会改变实践,使有经验的中心提供结构化的可选PMEG途径,并将决策到手术的时间从CMD物流通常需要的1-4个月缩短到几天(甚至几个小时),从而降低间隔破裂风险和患者焦虑。对于临床医生来说,这意味着一个更可预测的工作流程,可以缩短学习曲线,并在CMD可用性/成本有限的情况下扩大访问范围。
{"title":"Physician-Modified Endografts in Elective Care: A Report From the REgistry of MOdified Treo Endografts in Europe (REMOTE).","authors":"Csaba Csobay-Novák, Carlo Patrizio Dionisi, András Szentiványi, Ákos Bérczi, Péter Osztrogonácz, Angelo Di Sabato, Vaiva Dabravolskaite, Konstantinos Kotopoulos, Thomas R Wyss, Vladimir Makaloski","doi":"10.1177/15266028251405754","DOIUrl":"https://doi.org/10.1177/15266028251405754","url":null,"abstract":"<p><strong>Objective: </strong>Physician-modified endografts (PMEGs) are widely accepted as a viable option in the urgent management of patients with complex abdominal aortic aneurysms (CAAAs). While PMEGs have emerged as the predominant repair modality for CAAAs in the United States, their acceptance in Europe remains limited-particularly in the context of elective repair. The aim of this study was to present the initial experience with elective cases at pioneering European centers offering this treatment.</p><p><strong>Methods: </strong>This is a retrospective observational study based on an international multicenter registry (REgistry of MOdified Treo endografts in Europe-REMOTE). Data were collected from 4 European centers on patients who underwent elective PMEG repair using the Treo device for CAAAs between August 2023 and February 2025. Demographic characteristics, clinical status, procedural details and follow-up data were recorded. Primary outcomes included technical success, overall and aortic-related mortality, and adverse events.</p><p><strong>Results: </strong>Twenty-eight patients (20 males; mean age 76.3±6.8 years) underwent elective PMEG repair with the Treo device. Most procedures incorporated at least 3 target vessels (68.3%). The average time required for device modification was 47.4±20.3 minutes. Technical success was achieved in 96.4% of cases. The single technical failure was associated with a lost accessory renal artery, with no acute kidney injury occurred nor endoleak observed. There were no in-hospital deaths or major adverse events. At short-term follow-up (mean 5.9±4.8 months), overall mortality was 3.6% (n=1, non-aortic-related). Freedom from reintervention was 92.9% (n=26). Aneurysm sac shrinkage was observed in 25% of patients (n=7), with the remainder showing stability. Primary and secondary target vessel patency rates were both 98.8% (n=81), with one renal stent occlusion noted on follow-up imaging.</p><p><strong>Conclusion: </strong>This multicenter retrospective observational study demonstrated that elective PMEG repair of CAAAs using the Treo device is associated with a high-technical-success rate and a low incidence of clinical complications, supporting the safety and feasibility of this approach in the elective setting.Clinical ImpactREMOTE provides a multicentre European snapshot of elective PMEG-FEVAR on a single abdominal platform (Treo), showing high technical success with major clinical complications being uncommon, supporting feasibility in the elective setting. This could change practice by enabling experienced centres to offer a structured elective PMEG pathway and reduce decision-to-operation time from the 1-4 months often seen with CMD logistics to days (or even hours), thereby lowering interval-rupture risk and patient anxiety. For clinicians, this means a more predictable workflow that can shorten the learning curve and broaden access where CMD availability/cost is limiting.</p>","PeriodicalId":50210,"journal":{"name":"Journal of Endovascular Therapy","volume":" ","pages":"15266028251405754"},"PeriodicalIF":1.5,"publicationDate":"2026-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145935910","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lumbar Artery Branch in Treatment of Thoracoabdominal Aortic Aneurysm to Prevent Spinal Cord Ischemia. 腰动脉分支治疗胸腹主动脉瘤预防脊髓缺血。
IF 1.5 2区 医学 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2026-01-08 DOI: 10.1177/15266028251413517
Stephanie Rodriguez, Mathew Wooster

Purpose: This article describes the modification of an iliac limb to incorporate a lumbar artery branch to decrease risk of spinal cord ischemia (SCI) in a patient with a symptomatic extent III thoracoabdominal aortic aneurysm (TAAA).

Case report: A 59-year-old female with a history of zone 3 to 5 thoracic endovascular aortic repair 6 weeks prior for chronic type B3-10 dissection with 6.5 cm aneurysmal degeneration presented with sudden onset chest and abdominal pain. Imaging revealed rapid growth to 9.8 cm with a new stent graft-induced entry tear and associated fat stranding. Not medically fit for open repair, the patient was taken for an emergent fenestrated/branched endovascular aortic repair (F/BEVAR). A 32×24×150 TX2 Zenith thoracic tube graft was modified with 4 fenestrations. A 13×11×56 Z SLE Cook iliac limb was modified to create a custom iliac fenestrated endoprosthesis, as this patient's right iliac anatomy was not suitable for off-the-shelf products. After deployment of the custom iliac fenestrated device and fenestrated thoracic device, an aortogram revealed a large L5 lumbar artery we felt was amenable to fenestration to help preserve spinal perfusion. A 13×16×39 Z SLE Cook iliac limb was modified with a branch for an L5 lumbar artery. Post-operative course was uneventful without ischemic-related complications. One-month follow-up imaging reveals stable sac size with type II endoleak and patent hypogastric and lumbar artery stents.

Conclusion: Preservation of collateral pathways is understood to be critical in prevention of SCI, although the precise branches necessary are not clear. Lumbar fenestration and hypogastric preservation to reduce risk of SCI is a feasible and valid technique that should be considered when anatomy allows.Clinical ImpactThis case validates the efficacy and safety of using a physician-modified iliac limb to salvage an L5 lumbar artery after endovascular exclusion of a symptomatic extent III thoracoabdominal aortic aneurysm (TAAA). This interventional approach allows for the maintenance of perfusion to the spine and preservation of potentially hemodynamically significant collateral pathways. Our results suggest that this technique to mitigate the risk of spinal cord ischemia is safe and effective and thus may be considered for appropriately-selected cases.

目的:这篇文章描述了在症状程度为III型胸腹主动脉瘤(TAAA)的患者中,髂肢体的修改以纳入腰动脉分支以降低脊髓缺血(SCI)的风险。病例报告:一名59岁女性,6周前因慢性B3-10型夹层行3- 5区胸腔血管内主动脉修复术,并发6.5 cm动脉瘤变性,并发突发性胸腹疼痛。成像显示快速生长至9.8厘米,伴有新支架诱导的进入性撕裂和相关的脂肪搁浅。医学上不适合开放修复,患者被送往紧急开窗/分支血管内主动脉修复(F/BEVAR)。将32×24×150 TX2胸顶管移植物改良为4个开窗。由于该患者的右髂解剖结构不适合现成的产品,因此对13×11×56 Z SLE Cook髂肢体进行了修改,以创建定制的髂开窗内假体。在使用定制的髂骨开窗装置和胸骨开窗装置后,主动脉造影显示一条大的L5腰动脉,我们认为可以开窗以帮助保持脊柱灌注。用L5腰动脉分支改造13×16×39 Z SLE Cook髂肢体。术后过程顺利,无缺血性并发症。一个月的随访影像显示囊腔大小稳定,伴有II型内漏和未闭的胃下动脉和腰动脉支架。结论:侧支通路的保护被认为是预防脊髓损伤的关键,尽管所需的确切分支尚不清楚。腰椎开窗和胃下保存降低脊髓损伤的风险是一种可行和有效的技术,在解剖允许的情况下应予以考虑。临床影响:本病例验证了在血管内排除症状程度为III的胸腹主动脉瘤(TAAA)后,使用医师改良的髂肢体挽救L5腰动脉的有效性和安全性。这种介入方法可以维持脊柱的灌注,并保留潜在的血流动力学意义重大的侧支通路。我们的结果表明,这种技术减轻脊髓缺血的风险是安全有效的,因此可以考虑适当选择的病例。
{"title":"Lumbar Artery Branch in Treatment of Thoracoabdominal Aortic Aneurysm to Prevent Spinal Cord Ischemia.","authors":"Stephanie Rodriguez, Mathew Wooster","doi":"10.1177/15266028251413517","DOIUrl":"https://doi.org/10.1177/15266028251413517","url":null,"abstract":"<p><strong>Purpose: </strong>This article describes the modification of an iliac limb to incorporate a lumbar artery branch to decrease risk of spinal cord ischemia (SCI) in a patient with a symptomatic extent III thoracoabdominal aortic aneurysm (TAAA).</p><p><strong>Case report: </strong>A 59-year-old female with a history of zone 3 to 5 thoracic endovascular aortic repair 6 weeks prior for chronic type B<sub>3-10</sub> dissection with 6.5 cm aneurysmal degeneration presented with sudden onset chest and abdominal pain. Imaging revealed rapid growth to 9.8 cm with a new stent graft-induced entry tear and associated fat stranding. Not medically fit for open repair, the patient was taken for an emergent fenestrated/branched endovascular aortic repair (F/BEVAR). A 32×24×150 TX2 Zenith thoracic tube graft was modified with 4 fenestrations. A 13×11×56 Z SLE Cook iliac limb was modified to create a custom iliac fenestrated endoprosthesis, as this patient's right iliac anatomy was not suitable for off-the-shelf products. After deployment of the custom iliac fenestrated device and fenestrated thoracic device, an aortogram revealed a large L5 lumbar artery we felt was amenable to fenestration to help preserve spinal perfusion. A 13×16×39 Z SLE Cook iliac limb was modified with a branch for an L5 lumbar artery. Post-operative course was uneventful without ischemic-related complications. One-month follow-up imaging reveals stable sac size with type II endoleak and patent hypogastric and lumbar artery stents.</p><p><strong>Conclusion: </strong>Preservation of collateral pathways is understood to be critical in prevention of SCI, although the precise branches necessary are not clear. Lumbar fenestration and hypogastric preservation to reduce risk of SCI is a feasible and valid technique that should be considered when anatomy allows.Clinical ImpactThis case validates the efficacy and safety of using a physician-modified iliac limb to salvage an L5 lumbar artery after endovascular exclusion of a symptomatic extent III thoracoabdominal aortic aneurysm (TAAA). This interventional approach allows for the maintenance of perfusion to the spine and preservation of potentially hemodynamically significant collateral pathways. Our results suggest that this technique to mitigate the risk of spinal cord ischemia is safe and effective and thus may be considered for appropriately-selected cases.</p>","PeriodicalId":50210,"journal":{"name":"Journal of Endovascular Therapy","volume":" ","pages":"15266028251413517"},"PeriodicalIF":1.5,"publicationDate":"2026-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145935930","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Central Venous Stenosis and Occlusion in Dialysis Patients: A Technical and Outcome-Based Analysis of Endovascular Intervention. 透析患者中心静脉狭窄和闭塞:血管内介入的技术和结果分析。
IF 1.5 2区 医学 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2026-01-07 DOI: 10.1177/15266028251408988
Edoardo Pasqui, Giuseppe Galzerano, Elisa Lazzeri, Manfredi Giuseppe Anzaldi, Bruno Gargiulo, Leonardo Pasquetti, Michele Giubbolini, Gianmarco de Donato
<p><strong>Purpose: </strong>The purpose of the study is to evaluate the early and long-term technical and clinical outcomes of endovascular treatment for central venous stenosis (CVS) and occlusion (CVO) in hemodialysis patients, and to describe procedural strategies aiming at optimizing vascular access preservation.</p><p><strong>Materials and methods: </strong>A retrospective single-center analysis was performed including all patients with an upper-limb arteriovenous access undergoing endovascular revascularization for symptomatic CVS/CVO between January 2020 and December 2024. Indications comprised severe venous congestion, prolonged bleeding after dialysis, poor access maturation, and inadequate dialysis efficiency. Diagnosis was established by duplex ultrasound and computed tomography angiography; digital subtraction angiography was used when noninvasive imaging was inconclusive. Procedural details, device use, and perioperative outcomes were recorded. Primary outcome was primary patency; secondary outcomes included technical success, procedural safety, cumulative (secondary) patency, and freedom from reintervention.</p><p><strong>Results: </strong>Forty-four patients (mean age 65.8±16.2 years; 59.1% male) were treated, 50% for complete occlusions. The most frequent lesion site was the brachiocephalic vein (70.4%). High-pressure balloon angioplasty was performed in 93.2% of cases, and stents were implanted in 45.5% (mostly self-expanding nitinol). Technical success was achieved in 93.2% with no perioperative complications. Over a median follow-up of 36.7±32.2 months, 20 patients (45.5%) underwent reintervention for restenosis (34.1%) or reocclusion (11.4%); 30% of reinterventions revealed stent fractures. Kaplan-Meier analysis showed primary patency rates of 85.5% at 6 months, 69.9% at 12 months, and 58.7% at 18 months. Cumulative patency was 88.4% at 6 months, 80.9% at 12 and 24 months, 74.8% at 36 months, and 69.1% at 60 months. Prior ipsilateral central venous catheter placement was associated with reduced freedom from reintervention.</p><p><strong>Conclusions: </strong>Endovascular revascularization of CVS/CVO in hemodialysis patients is safe and offers high technical success. While primary patency declines over time, cumulative patency remains favorable, underscoring the role of timely reinterventions and structured surveillance in prolonging access life.Clinical ImpactThis study reinforces endovascular revascularization as a safe and effective first-line strategy for managing central venous stenosis and occlusion in hemodialysis patients, allowing immediate reuse of the vascular access and avoiding dialysis interruption. The data highlight that long-term success depends less on a single "perfect" procedure and more on structured surveillance and timely reintervention. Prior ipsilateral central venous catheter placement emerges as a key predictor of failure, underscoring the need to minimize catheter use and promote early AVF creation.
目的:本研究的目的是评估血液透析患者中心静脉狭窄(CVS)和闭塞(CVO)的血管内治疗的早期和长期技术和临床结果,并描述旨在优化血管通路保留的程序策略。材料和方法:对2020年1月至2024年12月期间所有接受上肢动静脉通道血管内重建术治疗症状性CVS/CVO的患者进行回顾性单中心分析。适应症包括严重静脉充血,透析后出血时间延长,通路成熟不良,透析效率不高。经双超声和计算机断层血管造影诊断;当无创成像不确定时,采用数字减影血管造影。记录手术细节、器械使用和围手术期结果。主要结局为原发性通畅;次要结局包括技术成功、手术安全、累积(次要)通畅和免于再干预。结果:治疗44例患者,平均年龄65.8±16.2岁,男性占59.1%,其中50%为完全性闭塞。最常见的病变部位为头臂静脉(70.4%)。高压球囊血管成形术占93.2%,支架植入术占45.5%(多为自膨胀镍钛诺)。技术成功率93.2%,无围手术期并发症。在36.7±32.2个月的中位随访中,20例(45.5%)患者因再狭窄(34.1%)或再闭塞(11.4%)进行了再干预;30%的再介入显示支架骨折。Kaplan-Meier分析显示,6个月时原发性通畅率为85.5%,12个月时为69.9%,18个月时为58.7%。6个月时累积通畅率为88.4%,12和24个月时为80.9%,36个月时为74.8%,60个月时为69.1%。先前的同侧中心静脉导管放置与再次干预的自由度降低有关。结论:血液透析患者血管内CVS/CVO血运重建术是安全的,技术成功率高。虽然初级通畅随着时间的推移而下降,但累积通畅仍然是有利的,这强调了及时的再干预和有组织的监测在延长可及寿命方面的作用。该研究强化了血管内血运重建术作为治疗血液透析患者中心静脉狭窄和闭塞的安全有效的一线策略,允许血管通道立即重用并避免透析中断。数据强调,长期成功较少依赖于单一的“完美”程序,而更多地依赖于有组织的监督和及时的再干预。先前的同侧中心静脉导管放置是失败的关键预测因素,强调需要尽量减少导管的使用并促进早期AVF的产生。从实用的角度来看,在长或容易反冲的病变中选择初级支架置入,并仔细注意支架的耐久性,可以有意义地延长这一脆弱人群的使用寿命。
{"title":"Central Venous Stenosis and Occlusion in Dialysis Patients: A Technical and Outcome-Based Analysis of Endovascular Intervention.","authors":"Edoardo Pasqui, Giuseppe Galzerano, Elisa Lazzeri, Manfredi Giuseppe Anzaldi, Bruno Gargiulo, Leonardo Pasquetti, Michele Giubbolini, Gianmarco de Donato","doi":"10.1177/15266028251408988","DOIUrl":"https://doi.org/10.1177/15266028251408988","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Purpose: &lt;/strong&gt;The purpose of the study is to evaluate the early and long-term technical and clinical outcomes of endovascular treatment for central venous stenosis (CVS) and occlusion (CVO) in hemodialysis patients, and to describe procedural strategies aiming at optimizing vascular access preservation.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Materials and methods: &lt;/strong&gt;A retrospective single-center analysis was performed including all patients with an upper-limb arteriovenous access undergoing endovascular revascularization for symptomatic CVS/CVO between January 2020 and December 2024. Indications comprised severe venous congestion, prolonged bleeding after dialysis, poor access maturation, and inadequate dialysis efficiency. Diagnosis was established by duplex ultrasound and computed tomography angiography; digital subtraction angiography was used when noninvasive imaging was inconclusive. Procedural details, device use, and perioperative outcomes were recorded. Primary outcome was primary patency; secondary outcomes included technical success, procedural safety, cumulative (secondary) patency, and freedom from reintervention.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Forty-four patients (mean age 65.8±16.2 years; 59.1% male) were treated, 50% for complete occlusions. The most frequent lesion site was the brachiocephalic vein (70.4%). High-pressure balloon angioplasty was performed in 93.2% of cases, and stents were implanted in 45.5% (mostly self-expanding nitinol). Technical success was achieved in 93.2% with no perioperative complications. Over a median follow-up of 36.7±32.2 months, 20 patients (45.5%) underwent reintervention for restenosis (34.1%) or reocclusion (11.4%); 30% of reinterventions revealed stent fractures. Kaplan-Meier analysis showed primary patency rates of 85.5% at 6 months, 69.9% at 12 months, and 58.7% at 18 months. Cumulative patency was 88.4% at 6 months, 80.9% at 12 and 24 months, 74.8% at 36 months, and 69.1% at 60 months. Prior ipsilateral central venous catheter placement was associated with reduced freedom from reintervention.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;Endovascular revascularization of CVS/CVO in hemodialysis patients is safe and offers high technical success. While primary patency declines over time, cumulative patency remains favorable, underscoring the role of timely reinterventions and structured surveillance in prolonging access life.Clinical ImpactThis study reinforces endovascular revascularization as a safe and effective first-line strategy for managing central venous stenosis and occlusion in hemodialysis patients, allowing immediate reuse of the vascular access and avoiding dialysis interruption. The data highlight that long-term success depends less on a single \"perfect\" procedure and more on structured surveillance and timely reintervention. Prior ipsilateral central venous catheter placement emerges as a key predictor of failure, underscoring the need to minimize catheter use and promote early AVF creation.","PeriodicalId":50210,"journal":{"name":"Journal of Endovascular Therapy","volume":" ","pages":"15266028251408988"},"PeriodicalIF":1.5,"publicationDate":"2026-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145913763","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Endovascular Therapy
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1